Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
How cyclic AMP (cAMP) could positively or negatively regulate G1 phase progression in different cell types or in cancer cells versus normal differentiated counterparts has remained an intriguing question for decades. At variance with the cAMP-dependent mitogenesis of normal thyroid epithelial cells, we show here that cAMP and cAMP-dependent protein kinase activation inhibit S-phase entry in four thyroid carcinoma cell lines that harbor a permanent activation of the Raf/ERK pathway by different oncogenes. Only in Ret/PTC1-positive TPC-1 cells did cAMP markedly inhibit the Raf/ERK cascade, leading to mTOR pathway inhibition, repression of cyclin D1 and p21 and p27 accumulation. p27 knockdown did not prevent the DNA synthesis inhibition. In the other cells, cAMP little affected these signaling cascades and levels of cyclins D or CDK inhibitors. However, cAMP differentially inhibited the pRb-kinase activity and T172-phosphorylation of CDK4 complexed to cyclin D1 or cyclin D3, whereas CDK-activating kinase activity remained unaffected. At variance with current conceptions, our studies in thyroid carcinoma cell lines and previously in normal thyrocytes identify the activating phosphorylation of CDK4 as a common target of opposite cell cycle regulations by cAMP, irrespective of its impact on classical mitogenic signaling cascades and expression of CDK4 regulatory partners.
Rocha
Ana Sofia
AS
Institute of Interdisciplinary Research (IRIBHM), Université Libre de Bruxelles, Campus Erasme, B-1070 Brussels, Belgium.
Paternot
Sabine
S
Coulonval
Katia
K
Dumont
Jacques E
JE
Soares
Paula
P
Roger
Pierre P
PP
D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D019925:Cyclin A / Q000378:metabolism; D056741:Cyclin D; D051358:Cyclin-Dependent Kinase 4 / Q000378:metabolism*; D018844:Cyclin-Dependent Kinases / Q000378:metabolism; D016213:Cyclins / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004789:Enzyme Activation / Q000187:drug effects; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006801:Humans; D009154:Mutation / Q000235:genetics; D010766:Phosphorylation / Q000187:drug effects; D011494:Protein Kinases / Q000378:metabolism; D048493:Proto-Oncogene Proteins B-raf / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D058570:TOR Serine-Threonine Kinases; D013964:Thyroid Neoplasms / Q000201:enzymology* / Q000473:pathology*; D000095043:Cyclin-Dependent Kinase-Activating Kinase
D019925:Cyclin A; D056741:Cyclin D; D016213:Cyclins; D004273:DNA, Neoplasm; D016160:Retinoblastoma Protein; D005576:Colforsin; D000242:Cyclic AMP; D011494:Protein Kinases; C546842:MTOR protein, human; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D058570:TOR Serine-Threonine Kinases; D017868:Cyclic AMP-Dependent Protein Kinases; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases; D048049:Extracellular Signal-Regulated MAP Kinases; D000095043:Cyclin-Dependent Kinase-Activating Kinase
Oncogene. 2005 Mar 17;24(12):2087-95
15688004
Cell Mol Life Sci. 1999 Feb;55(2):284-96
10188587
Genes Dev. 1999 Jun 15;13(12):1501-12
10385618
J Cell Sci. 1996 Jul;109 ( Pt 7):1759-64
8832398
Trends Biochem Sci. 2006 Dec;31(12):680-6
17084085
Cancer Res. 1992 Dec 15;52(24):6912-6
1333886
J Pediatr. 2000 Oct;137(4):585-7
11035845
Mol Cell Biol. 2006 Jul;26(13):5070-85
16782892
EMBO J. 1992 Feb;11(2):537-42
1371462
Mol Cell. 2007 Mar 23;25(6):839-50
17386261
Mol Cell Biol. 2002 Jun;22(11):3717-28
11997508
New Biol. 1989 Dec;1(3):297-304
2562123
Oncogene. 1999 Dec 2;18(51):7351-9
10602491
J Biol Chem. 1996 Aug 23;271(34):20608-16
8702807
Science. 1993 Nov 12;262(5136):1069-72
7694367
Mol Cell Biol. 1997 Sep;17(9):5598-611
9271435
J Biol Chem. 2006 Apr 7;281(14):9238-50
16452469
Endocrinology. 2001 Mar;142(3):1251-9
11181542
FEBS Lett. 1983 Jul 4;157(2):323-9
6305722
J Biol Chem. 2003 Sep 12;278(37):35394-402
12819211
Vitam Horm. 1995;51:59-191
7483330
Cancer Res. 2004 Jun 1;64(11):3823-9
15172989
Nat Rev Cancer. 2006 Apr;6(4):292-306
16557281
Endocr Relat Cancer. 2003 Dec;10(4):591-600
14713269
Biochem Biophys Res Commun. 1996 Jul 5;224(1):10-6
8694794
J Biol Chem. 2003 Jul 18;278(29):26533-40
12730225
Trends Biochem Sci. 1989 Feb;14(2):67-71
2539663
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14961-6
10611320
Mol Endocrinol. 2006 Dec;20(12):3279-92
16916940
J Clin Endocrinol Metab. 1997 Aug;82(8):2633-8
9253346
Nat Genet. 1994 Jul;7(3):396-401
7920658
Cell Div. 2006 Nov 08;1:25
17092340
Oncogene. 2003 Oct 23;22(48):7576-86
14576819
Annu Rev Biochem. 1975;44:491-522
166606
Science. 1990 Aug 10;249(4969):655-9
2116665
Exp Cell Res. 2003 Nov 15;291(1):135-49
14597415
Physiol Rev. 1976 Oct;56(4):652-708
185633
J Biol Chem. 2003 Aug 8;278(32):29819-23
12801936
J Cell Physiol. 1989 Jan;138(1):17-23
2536035
Genes Dev. 1994 Aug 1;8(15):1750-8
7958854
Mol Cell Biol. 1994 Nov;14(11):7265-75
7935441
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5152-6
1594625
Cancer Res. 2007 Aug 1;67(15):7106-12
17671177
Oncogene. 2003 Jul 17;22(29):4578-80
12881714
Mol Endocrinol. 2001 Feb;15(2):209-18
11158328
J Biol Chem. 1997 Oct 10;272(41):25863-72
9325318
Adv Cancer Res. 1974;19(0):303-29
4368553
J Cell Biol. 1992 Apr;117(2):383-93
1313816
Mol Cell. 2007 Mar 23;25(6):903-15
17386266
Endocrinology. 2006 Feb;147(2):1014-9
16254036
N Engl J Med. 1991 Dec 12;325(24):1688-95
1944469
J Cell Sci. 1993 Feb;104 ( Pt 2):545-55
8389378
Mol Biol Cell. 1998 Sep;9(9):2545-60
9725911
J Biol Chem. 2002 Mar 8;277(10):8517-23
11751903
Endocr Rev. 2001 Oct;22(5):631-56
11588145
J Biol Chem. 2001 Sep 7;276(36):33854-60
11457838
J Clin Endocrinol Metab. 1988 Jun;66(6):1158-65
2836470
J Clin Invest. 1991 May;87(5):1634-42
1673689
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10300-4
7694289
J Biol Chem. 1992 Jun 15;267(17):12307-10
1534806
J Cell Biol. 1998 Mar 23;140(6):1427-39
9508775
Endocrinology. 2007 Oct;148(10):4612-22
17584967
EMBO J. 1996 Dec 16;15(24):7060-9
9003781
Mol Cell Biol. 2003 Dec;23(24):9303-17
14645540
J Biol Chem. 2003 Dec 26;278(52):52052-60
14551212
Cell Cycle. 2006 Jan;5(1):61-70
16294008
Nat Rev Cancer. 2006 Sep;6(9):729-34
16915295
Genes Dev. 1997 Apr 1;11(7):847-62
9106657
Mol Cell Endocrinol. 2003 Dec 31;213(1):31-45
15062572
Mol Biol Cell. 2000 Mar;11(3):1061-76
10712520
Cell Cycle. 2007 Nov 15;6(22):2817-25
18032931
J Cell Sci. 2005 Nov 15;118(Pt 22):5171-80
16280550
Thyroid. 2007 Aug;17(8):707-15
17725429
Nat Genet. 2000 Sep;26(1):89-92
10973256
Oncogene. 1997 Apr 24;14(16):1981-90
9150365
Trends Cell Biol. 2002 Jun;12(6):258-66
12074885
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94
15342917
FEBS J. 2005 Jul;272(14):3491-504
16008550
Mol Endocrinol. 2006 Dec;20(12):3196-211
16887886
J Biol Chem. 1995 Sep 8;270(36):21411-9
7673177
Science. 2005 Feb 18;307(5712):1098-101
15718470
Int Rev Cytol. 1977;49:1-54
193803
Cell. 1994 Nov 4;79(3):487-96
7954814
J Biol Chem. 1997 May 9;272(19):12738-46
9139732
J Cell Biol. 1994 Oct;127(2):467-78
7929589
Nature. 1993 Oct 14;365(6447):649-51
8413627
Biochem J. 2002 Sep 1;366(Pt 2):673-80
12069688
J Biol Chem. 2007 Jul 6;282(27):20036-44
17510057